|
Description of populations and studies used for analyses of MC1R allele frequencies |
|||
| Population Name |
Description |
# Individuals |
Reference |
|
|
|||
| Africa |
Healthy subjects from South Africa (22 Negroid and 17 San people), 25 from South Africa, Nigeria, Zaire, Kenya and Gambia, and 53 from The Ivory Coast and Gambia |
117 |
John 2003, Rana 1999, Harding 2000 |
| India |
Healthy subjects from studies investigating MC1R variants. |
53 |
Rana 1999, Harding 2000 |
| Southern Europe |
Healthy subjects from Spain (188), Italy (495) and Greece (155) |
838 |
Fernandez 2007, Harding2000, Fargnoli 2003, Pastorino 2004, Landi 2005, Fargnoli 2006, Stratigos 2006, |
| Northern Europe |
Healthy subjects from The Netherlands (385), Britain/Ireland (93) and France (172) |
650 |
Bastiaens 2001, Kennedy 2001, Flanagan 2000, Harding 2000, Chaudru 2005 |
| Asia |
Healthy subjects from East and Southeast Asia. Rana et al reported individuals from China (50), Japan (4), Cambodia (1), Vietnam (1), Siberian Yakut (5) and Mongolia (4). The remaining studies were of individuals from Japan. |
343 |
Rana 1999, Harding 2000, Motokawa 2006, Nakayama 2006 |
| Papua New Guinea |
Healthy subjects from studies investigating MC1R variants. |
40 |
Harding 2000, Nakayama 2006 |
| United States |
Healthy Caucasian subjects participating in a population based study conducted in Philadelphia, PA and Caucasian spouse controls from the US in a familial melanoma case/control study. |
265 |
Kanetsky 2004, Goldstein 2005 |
Savage et al. BMC Genetics 2008 9:31 doi:10.1186/1471-2156-9-31 |
|||